TAK-783 ( DrugBank: - )
1 disease
| ID | Disease name (Link within this page) | Number of trials |
|---|---|---|
| 46 | Malignant rheumatoid arthritis | 4 |
46. Malignant rheumatoid arthritis
Clinical trials : 4,325 / Drugs : 2,671 - (DrugBank : 417) / Drug target genes : 187 - Drug target pathways : 224
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | EUCTR2006-003054-26-HU (EUCTR) | 22/05/2008 | 14/12/2007 | A Randomized, Double-Blind, Placebo-Controlled Proof of Concept Study to Evaluate the Safety and Efficacy of Oral TAK-783 in the Treatment of the Signs and Symptoms of in Subjects with Rheumatoid Arthritis | A Randomized, Double-Blind, Placebo-Controlled Proof of Concept Study to Evaluate the Safety and Efficacy of Oral TAK-783 in the Treatment of the Signs and Symptoms of in Subjects with Rheumatoid Arthritis | Rheumatoid arthritis (RA) MedDRA version: 8.1;Level: LLT;Classification code 10039073;Term: Rheumatoid arthritis | Product Code: TAK-783 | Takeda Global R&D (Europe) Ltd | NULL | Not Recruiting | Female: yes Male: yes | 230 | Hungary;Czech Republic;Latvia | |||
| 2 | EUCTR2006-003054-26-CZ (EUCTR) | 31/08/2007 | 06/08/2007 | A Randomized, Double-Blind, Placebo-Controlled Proof of Concept Study to Evaluate the Safety and Efficacy of Oral TAK-783 in the Treatment of the Signs and Symptoms of in Subjects with Rheumatoid Arthritis - NA | A Randomized, Double-Blind, Placebo-Controlled Proof of Concept Study to Evaluate the Safety and Efficacy of Oral TAK-783 in the Treatment of the Signs and Symptoms of in Subjects with Rheumatoid Arthritis - NA | Rheumatoid arthritis (RA) MedDRA version: 8.1;Level: LLT;Classification code 10039073;Term: Rheumatoid arthritis | Product Code: TAK-783 | Takeda Global R&D (Europe) Ltd | NULL | Not Recruiting | Female: yes Male: yes | 230 | Hungary;Czech Republic;Latvia | |||
| 3 | NCT00760968 (ClinicalTrials.gov) | August 2007 | 24/9/2008 | Efficacy and Safety of TAK-783 in Subjects With Rheumatoid Arthritis | A Randomized, Double-Blind, Placebo-Controlled Proof of Concept Study to Evaluate the Safety and Efficacy of Oral TAK-783 in the Treatment of the Signs and Symptoms in Subjects With Rheumatoid Arthritis | Arthritis, Rheumatoid | Drug: TAK-783 and methotrexate;Drug: Methotrexate | Takeda | NULL | Completed | 18 Years | N/A | Both | 224 | Phase 2 | Czech Republic;Latvia;Romania;Russian Federation;Slovakia;Ukraine |
| 4 | EUCTR2006-003054-26-LV (EUCTR) | 01/06/2007 | 12/09/2007 | A Randomized, Double-Blind, Placebo-Controlled Proof of Concept Study to Evaluate the Safety and Efficacy of Oral TAK-783 in the Treatment of the Signs and Symptoms of in Subjects with Rheumatoid Arthritis | A Randomized, Double-Blind, Placebo-Controlled Proof of Concept Study to Evaluate the Safety and Efficacy of Oral TAK-783 in the Treatment of the Signs and Symptoms of in Subjects with Rheumatoid Arthritis | Rheumatoid arthritis (RA) MedDRA version: 8.1;Level: LLT;Classification code 10039073;Term: Rheumatoid arthritis | Product Code: TAK-783 | Takeda Global R&D (Europe) Ltd | NULL | Not Recruiting | Female: yes Male: yes | 230 | Hungary;Czech Republic;Latvia |